A Multiple-Dose Targeting Study of hu3S193 [monoclonal antibody 3S193] in Patients With Small Cell Lung Cancer
Phase of Trial: Phase I
Latest Information Update: 23 Jun 2015
At a glance
- Drugs Monoclonal antibody 3S193 (Primary)
- Indications Small cell lung cancer
- Focus Adverse reactions
- 12 Sep 2005 New trial record.